Survival end point reporting in randomized cancer clinical trials: A review of major journals

Journal of Clinical Oncology

Volumn 26, Issue 22, 2008, Pages 3721-3726

  Mathoulin Pelissier, Simone ^a   Gourgou Bourgade, Sophie ^a   Bonnetain, Franck ^a   Kramar, Andrew ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; CANCER RESEARCH; CANCER SURVIVAL; HIGH RISK POPULATION; HUMAN; MEDLINE; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; TREATMENT OUTCOME; DISEASE COURSE; DISEASE FREE SURVIVAL; METHODOLOGY; MORTALITY; NEOPLASM; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; REVIEW; STANDARD; SURVIVAL;

DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; NEOPLASMS; PERIODICALS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 49249119155     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.14.1192     Document Type: Article

References (23)

1. Zelen M: Guidelines for publishing papers on cancer clinical trials: Responsibilities of editors and authors. J Clin Oncol 1:164-169, 1983
2. DerSimonian R, Charette LJ, McPeek B, et al: Reporting on methods in clinical trials. N Engl J Med 306:1332-1337, 1982
3. Chan AW, Altman DG: Identifying outcome reporting bias in randomised trials on PubMed: Review of publications and survey of authors. BMJ 330:753, 2005
4. Altman DG: Endorsement of the CONSORT statement by high impact medical journals: Survey of instructions for authors. BMJ 330:1056-1057, 2005
5. Hewitt C, Hahn S, Torgerson DJ, et al: Adequacy and reporting of allocation concealment: Review of recent trials published in four general medical journals. BMJ 330:1057-1058, 2005
6. Altman DG, De Stavola BL, Love SB, et al: Review of survival analyses published in cancer journals. Br J Cancer 72:511-518, 1995
7. Moher D, Jones A, Lepage L: Use of the CONSORT statement and quality of reports of randomized trials: A comparative before-and-after evaluation. JAMA 285:1992-1995, 2001
8. Begg C, Cho M, Eastwood S, et al: Improving the quality of reporting of randomized controlled trials: The CONSORT statement. JAMA 276:637-639, 1996
9. Clark TG, Bradburn MJ, Love SB, et al: Survival analysis part I: Basic concepts and first analyses. Br J Cancer 89:232-238, 2003
10. Punt CJ, Buyse M, Kohne CH, et al: Endpoints in adjuvant treatment trials: A systematic review of the literature in colon cancer and proposed definitions for future trials. J Natl Cancer Inst 99:998-1003, 2007
11. Hudis CA, Barlow WE, Costantino JP, et al: Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: The STEEP system. J Clin Oncol 25:2127-2132, 2007
12. Johnson JR, Williams G, Pazdur R: End points and United States Food and Drug Administration approval of oncology drugs. J Clin Oncol 21:1404-1411, 2003
13. Clark TG, Altman DG, De Stavola BL: Quantification of the completeness of follow-up. Lancet 359:1309-1310, 2002
14. Cohen J: Statistical Power Analysis for the Behavioral Sciences. New York, NY, Academic Press, 1977
15. Glynne-Jones R, Mawdsley S, Pearce T, et al: Alternative clinical end points in rectal cancer: Are we getting closer? Ann Oncol 17:1239-1248, 2006
16. Shuster JJ: Median follow-up in clinical trials. J Clin Oncol 9:191-192, 1991
17. Panageas KS, Ben-Porat L, Dickler MN, et al: When you look matters: The effect of assessment schedule on progression-free survival. J Natl Cancer Inst 99:428-432, 2007
18. Kober T, Trelle S, Engert A: Reporting of randomized controlled trials in Hodgkin lymphoma in biomedical journals. J Natl Cancer Inst 98:620-625, 2006
19. Dixon DO, McLaughlin P, Hagemeister FB, et al: Reporting outcomes in Hodgkin's disease and lymphoma. J Clin Oncol 5:1670-1672, 1987
20. Chua YJ, Sargent D, Cunningham D: Definition of disease-free survival: This is my truth-show me yours. Ann Oncol 16:1719-1721, 2005
21. Cookson MS, Aus G, Burnett AL, et al: Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 177:540-545, 2007
22. Journal of the National Cancer Institute: Instructions to Authors. http://www.oxfordjournals.org/our_journals/jnci/for_authors/index.html
23. De Angelis C, Drazen JM, Frizelle FA, et al: Clinical trial registration: A statement from the International Committee of Medical Journal Editors. N Engl J Med 351:1250-1251, 2004